The Goldman Sachs Group, Inc. 13D and 13G filings for ProQR Therapeutics N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-07 6:11 pm Sale | 2022-12-30 | 13G | ProQR Therapeutics N.V. PRQR | GOLDMAN SACHS GROUP INC GS | 9,164 0.000% | -3,964,486 (-99.77%) | Filing |
| 2022-02-07 1:57 pm Purchase | 2021-12-31 | 13G | ProQR Therapeutics N.V. PRQR | GOLDMAN SACHS GROUP INC GS | 3,973,650 5.600% | 467,286 (+13.33%) | Filing |